{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:46:39Z","timestamp":1769208399743,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10067-017-3677-7","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T08:16:46Z","timestamp":1495441006000},"page":"1827-1832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum prolidase activity in systemic sclerosis"],"prefix":"10.1007","volume":"36","author":[{"given":"Ahmet","family":"Celik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Nur","family":"Birer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Kilinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"issue":"5","key":"3677_CR1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/berh.2002.0258","volume":"16","author":"G Valentini","year":"2002","unstructured":"Valentini G, Black C (2002) Systemic sclerosis. Best Pract Res Clin Rheumatol 16(5):807\u2013816","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"3677_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"AT Masi","year":"1980","unstructured":"Masi AT (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581\u2013590","journal-title":"Arthritis Rheum"},{"key":"3677_CR3","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV, Beebe-Dimmer J (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246\u20132255","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3677_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-2-200401200-00013","volume":"140","author":"SA Jimenez","year":"2004","unstructured":"Jimenez SA, Derk CT (2004) Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 140(1):37\u201350","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"3677_CR5","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar2188","volume":"9","author":"T Krieg","year":"2007","unstructured":"Krieg T, Abraham D, Lafyatis R (2007) Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions. Arthritis Res Ther 9(Suppl 2):S4","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3677_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00281-015-0508-2","volume":"37","author":"A Leask","year":"2015","unstructured":"Leask A (2015) Semin Immunopathol 37(5):559\u2013563","journal-title":"Semin Immunopathol"},{"issue":"8","key":"3677_CR7","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1016\/S0021-9258(18)83768-1","volume":"264","author":"F Endo","year":"1989","unstructured":"Endo F, Tanoue A, Nakai H, Hata A, Indo Y, Titani K et al (1989) Primary structure and gene localization of human prolidase. J Biol Chem 264(8):4476\u20134481","journal-title":"J Biol Chem"},{"issue":"10","key":"3677_CR8","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1021\/bi0356451","volume":"43","author":"MJ Maher","year":"2004","unstructured":"Maher MJ, Ghosh M, Grunden AM, Menon AL, Adams MW, Freeman HC et al (2004) Structure of the prolidase from Pyrococcus furiosus. Biochemistry 43(10):2771\u20132783","journal-title":"Biochemistry"},{"key":"3677_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinchem\/30.2.211","volume":"30","author":"I Myara","year":"1984","unstructured":"Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A (1984) Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 30:211\u2013215","journal-title":"Clin Chem"},{"key":"3677_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/CMAMD.S12602","volume":"6","author":"D Ucar","year":"2013","unstructured":"Ucar D, Em S, Bozkurt M, Oktayoglu P, Yuksel HK, Caglayan M et al (2013) Serum prolidase activity in ankylosing spondylitis and rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 6:29\u201333","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"2","key":"3677_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1179\/1351000213Y.0000000072","volume":"19","author":"M Bozkurt","year":"2014","unstructured":"Bozkurt M, Y\u00fcksel H, Em S, Oktayoglu P, Yildiz M, Akdeniz D et al (2014 Mar) Serum prolidase enzyme activity and oxidative status in patients with Beh\u00e7et's disease. Redox Rep 19(2):59\u201364","journal-title":"Redox Rep"},{"issue":"5","key":"3677_CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/adc.76.5.441","volume":"76","author":"M Shrinath","year":"1997","unstructured":"Shrinath M, Walter J, Haeney M, Couriel J, Lewis M, Herrick A (1997) Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child 76(5):441\u2013444","journal-title":"Arch Dis Child"},{"key":"3677_CR13","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R et al (1995) Inter and intraobserver variability of total skin thickness score (modi ed Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281\u20131285","journal-title":"J Rheumatol"},{"key":"3677_CR14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","volume":"60","author":"G Valentini","year":"2001","unstructured":"Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D\u2019Angelo S et al (2001) European multicenter study to de ne disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592\u2013598","journal-title":"Ann Rheum Dis"},{"key":"3677_CR15","first-page":"2159","volume":"26","author":"TA Medsger Jr","year":"1999","unstructured":"Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159\u20132167","journal-title":"J Rheumatol"},{"key":"3677_CR16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(82)90196-6","volume":"125","author":"I Myara","year":"1982","unstructured":"Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline calorimetric determination: application to iminodipeptiduria. Clin Chim Acta 125:193\u2013205","journal-title":"Clin Chim Acta"},{"key":"3677_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9258(18)44814-4","volume":"199","author":"FP Chinard","year":"1952","unstructured":"Chinard FP (1952) Photometric estimation of proline and ornithine. J Biol Chem 199:91\u201395","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"3677_CR18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00508-014-0534-4","volume":"126","author":"E Savas","year":"2014","unstructured":"Savas E, Aksoy N, Pehlivan Y, Sayiner ZA, Ozt\u00fcrk ZA, Tabur S et al (2014) Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis. Wien Klin Wochenschr 126(11\u201312):341\u2013346","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"3677_CR19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0006-291X(86)80591-5","volume":"138","author":"J Varga","year":"1986","unstructured":"Varga J, Jimenez SA (1986) Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta. Biochem Biophys Res Commun 138(2):974\u2013980","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3677_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1084\/jem.165.1.251","volume":"165","author":"AE Postlethwaite","year":"1987","unstructured":"Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 165(1):251\u2013256","journal-title":"J Exp Med"},{"key":"3677_CR21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/16066350500095415","volume":"38","author":"LI Sakkas","year":"2005","unstructured":"Sakkas LI (2005) New developments in the pathogenesis of systemic sclerosis. Autoimmunity 38:113\u2013116","journal-title":"Autoimmunity"},{"key":"3677_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jdermsci.2007.05.014","volume":"49","author":"H Ihn","year":"2008","unstructured":"Ihn H (2008) Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 49:103\u2013113","journal-title":"J Dermatol Sci"},{"key":"3677_CR23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE (2015) Pathogenesis of systemic sclerosis. Front Immunol 6:272","journal-title":"Front Immunol"},{"issue":"1","key":"3677_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdermsci.2008.04.013","volume":"52","author":"S Tomimura","year":"2008","unstructured":"Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E et al (2008) Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. J Dermatol Sci 52(1):47\u201354","journal-title":"J Dermatol Sci"},{"key":"3677_CR25","first-page":"6","volume":"15","author":"C Kayser","year":"2015","unstructured":"Kayser C, Fritzler MJ (2015) Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol 15:6\u2013167","journal-title":"Front Immunol"},{"issue":"1","key":"3677_CR26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0006-291X(05)81307-5","volume":"180","author":"WL Mock","year":"1991","unstructured":"Mock WL, Zhuang H (1991) Chemical modification locates guanidinyl and carboxylate groups within the active site of prolidase. Biochem Biophys Res Commun 180(1):401\u2013406","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl","key":"3677_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ard.36.Suppl_2.26","volume":"36","author":"MIV Jayson","year":"1977","unstructured":"Jayson MIV (1977) Collagen changes in the pathogenesis of systemic sclerosis. Ann Rheum Dis 36(Suppl):26","journal-title":"Ann Rheum Dis"},{"key":"3677_CR28","doi-asserted-by":"crossref","first-page":"19606","DOI":"10.1016\/S0021-9258(17)45415-9","volume":"265","author":"WL Mock","year":"1990","unstructured":"Mock WL, Green PC (1990) Mechanism and inhibition of prolidase. J Biol Chem 265:19606\u201319610","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"3677_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00508-015-0734-6","volume":"128","author":"H Kayadibi","year":"2016","unstructured":"Kayadibi H, Sertoglu E, Uyanik M (2016) High proline-related inhibition of serum prolidase enzyme activity in scleroderma. Wien Klin Wochenschr 128(3\u20134):155","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"3677_CR30","first-page":"480","volume":"117","author":"ES Namiduru","year":"2016","unstructured":"Namiduru ES (2016) Prolidase. Bratisl Lek Listy 117(8):480\u2013485","journal-title":"Bratisl Lek Listy"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3677-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T19:43:50Z","timestamp":1659037430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3677-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3677"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3677-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]}}}